Oxitropium bromide is an anticholinergic bronchodilator medication used for the treatment of chronic obstructive pulmonary disease (COPD) and asthma. It is not available in the United States but is used in many other countries, including Japan and those in Europe. It is grouped under the following drug class(es): Anticholinergics and Bronchodilators. Its therapeutic use is listed as anti-asthmatic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Oxivent, Ventilat and Tersigan. Its PubChem CID is 6917865.
Oxitropium bromide
| CAS No | 30286-75-0 |
|---|---|
| Molecular Formula | C19H26BrNO4 |
| Molecular Weight | 412.3 g/mol |
| Synonyms | [(1R,2R,4S,5S)-9-ethyl-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate bromide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Oxitropium bromide is an anticholinergic bronchodilator medication used for the treatment of chronic obstructive pulmonary disease (COPD) and asthma. It is not available in the United States but is used in many other countries, including Japan and those in Europe.
The listed CAS number is 30286-75-0.
The listed molecular formula is C19H26BrNO4.
The listed molecular weight is 412.3 g/mol.
[(1R,2R,4S,5S)-9-ethyl-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate bromide.
The source lists Oxivent, Ventilat and Tersigan.